Policy Watch: Does the Government ‘Blueprint’ to Lower Drug Prices Help Neurology?

Oct 18, 2018

Policy Watch: Does the Government 'Blueprint' to Lower Drug Prices Help Neurology?

Policy Watch: Does the Government ‘Blueprint’ to Lower Drug Prices Help Neurology?

After all, neurology drugs, particularly those for multiple sclerosis, and for orphan conditions such as spinal muscular atrophy and Duchenne muscular ... read more

Published on 2018-10-18